Suzetrigine is a prescription pill taken every 12 hours after a larger starter dose. The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

The US medicines regulator approved a new type of pain pill that aims to eliminate the risks of addiction and overdose associated with medications that launched the US into an opioid epidemic more ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute ...

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while ...

There’s a lot of buzz surrounding the new non-addictive pain pill that is up for FDA approval. It works as well as opioids for treating acute pain, and shows promise in treating chronic neuropathic ...

Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes increasingly crucial. While these pills may offer temporary relief, their potential ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription ...